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Nigella sativa L. (NS) has been used for medicinal purposes since ancient times. This study aimed to investigate the cytotoxicity
of NS dry methanolic extract on cultured cortical neurons and its inﬂuence on neurotransmitter release, as well as the presence of
excitatory(glutamateandaspartate)andinhibitoryaminoacids(gamma-aminobutyricacid—GABA—andglycine)inNSextract.
Cultured rat cortical neurons were exposed to diﬀerent times and concentrations of NS dry methanolic extract and cell viability
was then determined by a quantitative colorimetric method. NS did not induce any toxicity. The secretion of diﬀerent amino acids
was studied in primary cultured cortical neurons by high-performance liquid chromatography (HPLC) using a derivation before
injection with dansyl chloride. NS modulated amino acid release in cultured neurons; GABA was signiﬁcantly increased whereas
secretion of glutamate, aspartate, and glycine were decreased. The in vitro ﬁndings support the hypothesis that the sedative and
depressive eﬀects of NS observed in vivo could be based on changes of inhibitory/excitatory amino acids levels.
1.Introduction
Nigella sativa L. (NS) is a vegetal specie of the Ranunculaceae
family, commonly known as “black cumin seed”, “neguilla”
or “ajemuz”, that is widely cultivated in the Mediterranean
region. Its seeds have played an important role over the years
in ancient Islamic system of herbal medicine and in Spain,
where they have been traditionally used in folk medicine.
NS seeds have shown several therapeutic eﬀects such as
prevention of cancer [1], antihypertensive eﬀect [2], anti-
inﬂammatory, analgesic [3], and antihistaminic [4] actions.
These properties have been proved and documented by
recent research [5–10].
The volatile oil from this plant presents a relaxant action
on diﬀerent smooth muscles [11] and tracheal muscles
of guinea pigs [12]. There is evidence of anticonvulsant
and antioxidant eﬀects against pentylenetetrazol-induced
kindling in mice [13]. In addition, it is more potent as an
anticonvulsant agent than valproate [13]. Likewise, aqueous
extract of this plant suppresses penicillin-induced epileptic
activity in rats. This anticonvulsant eﬀect is a consequence
of selectively altering the monoamine level in diﬀerent brain
regions [14].
In recent works, histopathological changes of neurode-
generation in the frontal cortex and brain stem in neu-
rons after exposition to toluene have been observed [15,
16]. The administration of NS extract and thymoquinone
(major component from NS volatile oil) causes morphologic
improvement over apoptosis and indicates that NS therapy
is useful as a potential treatment of neurodegeneration
prevention.
NS seeds composition includes nutritional components
such as carbohydrates (glucose, xylose, rhamnose, and ara-
binose), vitamins as thiamine, riboﬂavin, pyridoxine, niacin
and folic acid [5], mineral elements, and proteins. The NS2 Journal of Biomedicine and Biotechnology
seeds are also a source of calcium, iron and potassium, alka-
loids (nigellidine, nigellimine, and nigellicine) [17], 36%–
38% ﬁxed oil and 0.4%–2.5% essential oil [18]. The ﬁxed oil
is mainly composed of unsaturated and essential fatty acids
(linoleicacid,followedbyoleicacid)[19]whereasthevolatile
oil has been shown to contain 18.4–24% thymoquinone and
46% monoterpenes such as p-cymene and pinene [5, 20].
Thimoquinone, as indicated above, is thought to be the
main active component of NS seeds [18] and suppresses
itself epileptic seizures in rats [21], while a monodesmosidic
triterpene saponin, α-hederin, has also been isolated from
the extract of NS seeds and proved to exert antitumoral
activity [22].
Other active principles are nigellone and nigellidine
which contains an indazol nucleus [23]. Three ﬂavonoid
glycosides and triterpene saponins were also identiﬁed
from Nigella sativa, together with four phospholipid
classes: phosphatidylcholine phosphatidylethanolamine,
phosphatidylserine, and phosphatitdylinositol [24, 25].
In previous studies we demonstrated that aqueous and
methanolic extracts of NS seeds exert a potent sedative
and depressive eﬀect on CNS and induce analgesia [26].
The eﬀect on CNS resulted in a signiﬁcant reduction
of spontaneous motility, a decrease in normal body
temperature and signiﬁcant analgesic action against hot-
plate and pressure tests. Body temperature reduction can
be interpreted as an index of alteration of various central
neurotransmitters;anxietyandsedationaremainlymediated
by the GABA-A receptor in the CNS. Since depressant action
was conﬁrmed specially for the methanolic extract, we
decided to study whether the addition of this methanolic
dry extract in cortical neurons culture could exert any
inﬂuence on the secretion of the excitatory amino acids
aspartate (Asp) and glutamate (Glu), and the inhibitory
amino acids GABA and glycine (Gly), as well as the presence
of these amino acid neurotransmitters in the extract. We
also considered its eﬀect on the amino acids secretion when
stimulated by a depolarizing agent and its eﬀect on cultured
neurons viability.
2. Results
2.1. Cell Viability. The viability of the cultured neurons
after exposition to NS extract concentrations 2.5, 25, and
250μg/mL during 15 and 60minutes are shown in Figure 1.
No signiﬁcant changes were observed on neuronal viability
at any assayed concentration. Results are expressed as a
percentage with respect to control value (100% viability).
2.2. Amino Acids Determination
2.2.1. Amino Acids Determination in the NS Extract. The
amino acids GABA, Gly, Glu, and Asp were measured in
NS methanolic extract by HPLC. The results are expressed
as pmoles/mg of NS extract (Table 1). The results showed
Gly as the most abundant, followed by GABA, Glu, and
Asp, respectively. The amino acids content in the extract was
subtractedfromthetotalaminoacidcontentmeasuredinthe
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Figure 1: Eﬀect of Nigella sativa methanolic extract on neuronal
viability measured by MTT assay. The cells were stimulated for 15
and 60minutes with diﬀerent concentrations of this extract (2.5,
25 and 250μ/mL, ﬁnal concentration). The results are presented as
± SEM of three independent experiments and statistical analysis
resulted in no signiﬁcant diﬀerences when compared with the
control group.
cellular medium after neuronal stimulation with NS extract
so we can state that the ﬁnal amino acids content in cell
culture is a direct consequence of cell release.
2.2.2. Amino Acids Release in Presence of NS Extract. The
release of the four amino acids after stimulation with the
chosen nontoxic concentrations of NS extract (2.5, 25, and
250μg/mL)showedadiminishedsecretionresponsethatwas
statistically signiﬁcant (P<. 05 for Gly and Glu; P<. 01
for GABA; P<. 001 for Asp) after 15minutes of incubation
with respect to control (neuronal cells stimulated with
normal Locke medium during the same period of time and
considered as 100% secretion) (Figures 2, 3, 4,a n d5). Gly
and Asp release was reduced in a dose dependent manner;
Glu and GABA showed a tendency to retrieve control values,
although their secretion was lower than control. This fall of
aminoacidsreleaseisgreaterforhigherextractconcentration
except for Glu and GABA, which showed a tendency to
recuperation to control values at the same time (Figure 2).
The HPLC analysis revealed the same behavior for all the
amino acids, with the exception of GABA, after treatment
with NS extract during 60minutes. The increased presence
of this amino acid was statistically signiﬁcant for 25 and
250μg/mL NS extract.
2.2.3. Amino Acid Release Evoked by 60mM KCl. In order to
know the response to a depolarizing agent, cortical neurons
were stimulated with NS extract at the indicated concentra-
tions, during 15 and 60minutes previous to depolarization
with 60 mM KCl (Figures 6 and 7).
The neurons treated with NS extract during 15minutes
and subsequently stimulated with KCl showed a dose-
dependent decrease in amino acids secretion with respectJournal of Biomedicine and Biotechnology 3
Table 1: Amino acids composition of methanolic extract of Nigella sativa. The results are expressed as pmoles of each amino acid by mg of
methanolic extract, prepared under the conditions indicated in experimental procedures.
Amino acid Asp Glu Gly GABA
pmoles/mg NS
Methanolic extract
234.64 ± 8.03 345.26 ± 11.82 1943.28 ± 51.8 396.24 ± 13.59
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Figure 2: Eﬀect produced by diﬀerent concentrations (2.5, 25,
and 250μg/mL) of methanolic extract of Nigella sativa on GABA
release from cortical neurons. The cells were stimulated for 15 and
60minutes with each concentration. The values are expressed as a
percentage of secretion with respect to basal value (100%). Statisti-
cal signiﬁcances were calculated with respect to the corresponding
control at its respective time points:
∗∗P <. 01;
∗∗∗P< . 001.
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Figure 3: Eﬀect produced by diﬀerent concentrations (2.5, 25,
and 250 μg/mL) of methanolic extract of Nigella sativa on
Glycine release from cortical neurons. The cells were stimulated
for 15 and 60minutes with each concentration. The values are
expressed as a percentage of secretion with respect to basal value
( 100%). Statistical signiﬁcances were calculated with respect to the
corresponding control at its respective time points:
∗P <. 05 and
∗∗∗P <. 001.
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Figure 4: Eﬀect produced by diﬀerent concentrations (2.5, 25, and
250μg/mL) of methanolic extract of Nigella sativa on Glutamate
release from cortical neurons. The cells were stimulated for 15 and
60 minutes with each concentration. The values are expressed as a
percentage of secretion with respect to basal value (100%). Statis-
tical signiﬁcances were evaluated with respect to the corresponding
control at its respective time points:
∗P <. 05 and
∗∗∗P <. 001.
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Figure 5: Eﬀect produced by diﬀerent concentrations (2.5, 25, and
250μg/mL) of methanolic extract of Nigella sativa on Aspartate
release from cortical neurons. The cells were stimulated for 15 and
60minutes with each concentration. The values are expressed as a
percentage of secretion with respect to basal value (100%). Statisti-
cal signiﬁcances were calculated with respect to the corresponding
control at its respective time points:
∗∗∗P <. 001.4 Journal of Biomedicine and Biotechnology
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Figure 6: Secretion of amino acid neurotransmitters evoked by
60 mM KCl, measured in cortical neurons culture. The cells were
previously treated with methanolic extract of Nigella sativa for 15
minutes. The values are expressed as a percentage of secretions
with respect to basal value (100%). Statistical signiﬁcances were
calculatedwithrespecttothecorrespondingcontrolatitsrespective
time points:
∗P <. 05,
∗∗P <. 01 and
∗∗∗P <. 001.
to control value (neuronal cells stimulated with Locke
medium), which was considered as 100%. The observed
behaviour was more relevant for Glu and Asp at 25 and 250
μg/mL than for GABA and Gly under the same conditions
(Figure 6).
Measurement of secretion mediated by KCl during
60minutes revealed an inhibition of the liberation of these
neurotransmitters. In this case, only GABA and Glu were
released in a dose-dependent manner (Figure 7).
3. Discussion
The aim of the study was to determine the eﬀects of NS
methanolic extract on the release of neurotransmitter amino
acids by measuring their concentrations in the culture media
using HPLC precolumn derivatization technique. Three
concentrations of NS extract (2.5, 25, and 250μg/mL) and
two time points (15 and 60min) for the determination of the
eﬀects were used. This is a preliminary study which shows
that exposure of the cultured neurons have a modulatory
eﬀect on the release and contents of these aminoacids.
The 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium
bromide (MTT) assay was employed to estimate the cells
viability when neurons were treated with NS extract. The
three concentrations of dry methanolic extract used in
our study did not aﬀect cellular respiratory capacity at
any of the two periods of time considered. These results
allowed us to consider the adequate approach to the study
of amino acid secretion in the conditions selected and to
conﬁrm the innocuous characteristics of the chosen extract
concentrations.
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Figure 7: Secretion of amino acid neurotransmitters evoked by
60 mM KCl, measured in cortical neurons culture. The cells were
previously treated with methanolic extract of Nigella sativa for 60
minutes. The values are expressed as a percentage of secretions
with respect to basal value (100%). Statistical signiﬁcances were
calculatedwithrespecttothecorrespondingcontrolatitsrespective
time points:
∗P <. 05 and
∗∗∗P <. 001.
Our previous in vitro ﬁndings support the hypothesis
that the sedative and depressive eﬀects of Nigella sativa
(NS) observed in vivo [26], could be based on changes
of inhibitory/excitatory amino acids levels. Several authors
attribute the sedative eﬀects of diﬀerent plant extracts
(Valeriana oﬃcinalis L., Scutellaria lateriﬂora L.) [27, 28]
to its endogenous GABA concentration, although they also
hypothesize that there exist other components of the vegetal
extracts with benzodiazepine-like eﬀects that may account
for their in vivo eﬀects. The aim of our research was to
determine whether these substances that are present in the
NS extract could mediate the speciﬁc eﬀects previously
observed in vivo through the secretion of Asp, Glu, GABA,
and Gly.
First of all, the presence and content of the four amino
acids in the extract was analyzed by HPLC, showing a
major presence of inhibitory amino acids (Gly and GABA)
(Table 1).
Then, the cell amino acids release was assayed after
addition of several concentrations of NS extract to cultured
neurons during two diﬀerent periods of time (15 and
60minutes). The aim of this approach was to observe
whether neuronal secretion could be modiﬁed depending
on the exposition time. High secretion of GABA was
observed after 60minutes’ contact with NS extract at 25 and
250μg/mL. This time is close to the one that allowed the
maximum eﬀect in our in vivo study, close to 40minutes
[26].
Under these conditions, neuronal GABA was liberated to
the medium. Similar results have been observed when high
GABA concentrations are present in an aqueous extract of
Valeriana oﬃcinalis root which induced in vitro liberationJournal of Biomedicine and Biotechnology 5
of [ 3H]GABA in rat synaptosomes by reversal of the GABA
carrier and inhibition of its reuptake [27]. Subsequently, it
was described the same behavior for Scutellaria lateriﬂora L.
[28]. Both plants are widely prescribed as sedative/anxiolytic
ones. As the GABA presence in the methanolic extract of NS
was conﬁrmed with our results, it is possible to assume that a
highlevelofGABAinthemediumduringcellularincubation
and a longer period of exposition at this one could exert the
same eﬀect above described.
Recent ﬁndings suggest that NS protects from induced
generalized epilepsy in rats by selectively altering the
monoamine level in diﬀerent brain regions [14]. This study
pointed that NS possibly facilitates the inhibitory activity
of the GABAergic system through a competitive agonist
action in the benzodiazepine (BZD) site of the GABA
receptor as well as the involvement of dopaminergic and
noradrenergic system. The conﬁrmed presence of GABA
in the methanolic extract could be directly related to its
conduct over the GABA receptor and this could explain the
potent sedative and depressive eﬀect on CNS as previously
reported. Moreover, the important presence of Gly in the
extract could be also related to its inhibitory action. The
binding of both neurotransmitters to their receptors on the
neuronal membrane induces hyperpolarization that could
be responsible for a signiﬁcantly lower secretion of amino
acids with respect to control values. In addition to this,
our results showed a decrease in neuronal excitatory activity
derived from a diminished Asp and Glu secretion, specially
the second one. These actions could also be concurrent with
the in vivo observed eﬀects.
Our results show the behavior of the cortical neurons
and conﬁrm what we expected from the previous study
performed in vivo. Likewise the methanolic extract composi-
tion is able to mediate in the neuronal amino acids release.
In this case, the NS extract had an inﬂuence on neuronal
transmissionbecauseitmodiﬁestheneurotransmitteramino
acids release.
Depolarization of neuronal cells by application of high
K+concentration(60mMKCl)inducedadiminishedamino
acid release in both periods of time assayed. This diminished
release was similar to nondepolarizing secretion except
for GABA which also diminished its secretion. Although
multiple mechanisms of neurotransmitter release evoked
by elevated extracellular K+ may be involved [29, 30], we
consider that the eﬀect of NS extract over neuronal cells
produces a drop in the transmission and is responsible for
of the inhibitory eﬀect indicated above. A possible action of
NS extract over L-Type Calcium channels or an opening on
potassium channels had been suggested by others authors
[31–35], and it could contribute to the relaxant activities
of this plant. Furthermore, its possible eﬀect over these
channels could persist even after the extract was eliminated
from the medium before depolarization.
With respect to GABA secretion, the only amino acid
which diﬀers in its behavior with respect to nondepolarizing
liberation, the diminished secretion may derivate from the
membrane transporter-reversal for GABA above suggested.
In our study, we have considered the possibility that the
G A B Ac a r r i e rh a db e e np r e v i o u s l ya ﬀected by the presence
of NS extract during 15 or 60minutes, inhibiting GABA
reuptake and favouring its liberation from neurons. Other
authors [30] have concluded that extracellular K+ (50mM
KCl) provokes GABA release by reversal transporter of
GABA. In our case, we observed a diminished liberation
that could be justiﬁed by the previous loss of cellular GABA
content as the neurons had been treated with the NS extract.
In conclusion, this study suggests a sedative eﬀect of
NS methanolic extract by modiﬁcation of neurotransmitter
amino acids release, because the NS extract may induce
an important release of GABA and Gly in the cultured
neurons medium and therefore, exert an increase in the
agonist action over their receptors. The results explain the
sedativeanddepressiveeﬀectsobservedinvivobyanincrease
in inhibitory amino acids at the synaptic terminals. Even
more, this eﬀect is complemented with a possible decrease of
excitatory transmission, as it has been demonstrated in vitro
and could contribute to inhibitory response.
4.ExperimentalProcedures
4.1.Materials. MinimumEssentialEagle’sMedium(EMEM)
was obtained from Bio-Whittaker, and Foetal Bovine Serum
(FBS) and Horse Serum (HS) were procured from Sera-Lab
(Sussex,England).StandardsofGlutamate,Aspartate,GABA
and Glycine were purchased from Sigma (St. Louis, Mo,
USA). Reagents and solvents for HPLC were Triethylamine
from Sigma (St. Louis, Mo, USA), Acetic acid and Methanol
ultra gradient grade from Merck (Darmstadt, Germany).
Other chemicals were reagent grade products from Merck
(Darmstadt, Germany).
Distilled water used for the preparation of buﬀers and
standards was deionized with Milli-Q puriﬁcation system.
Syringe ﬁlters Millex-GV were obtained from Millipore
(Milford, MA, USA).
Membrane ﬁlters (0.45μm pore size) from Teckno-
chroma (Barcelona, Spain) were used for ﬁltration of the
mobile phase and samples. Cell Proliferation kit II (XTT),
colorimetric determination, was purchased from Roche
Diagnostics GmbH (Mannheim, Germany).
4.2. Instruments. An HPLC system (Spectra Physics Model
SP 4400; San Jos´ e, Calif., USA) coupled with a photodiode
array detector Shimadzu SPD-10A (Izasa, Madrid, Spain)
was used for the amino acids isolation and quantiﬁcation.
The analytical system consisted of a Waters ODS Spherisorb
150 × 4.6mm I.D.; 5μm packed column (Teknokroma,
Barcelona, Spain) as stationary phase, preceded by a guard
column Spherisorb RP-18, 5μm, 4mm ×4 mm.
A microplate ﬂuorescence reader FL600-BioTek spec-
troﬂuorimeterwasusedforthequantiﬁcationofcellviability
at 492nm.
4.3. Nigella sativa Extract. Seeds of Nigella sativa L. were
supplied by the Medicinal and Aromatic Plants research
InstituteofEgypt(ElCairo,Egypt).Herbariumsampleswere
authenticated by a taxonomist and a voucher specimen was
deposited in the Herbarium of the Faculty of Pharmacy,6 Journal of Biomedicine and Biotechnology
Universidad Complutense de Madrid, with voucher number
MAF 161043. The methanolic extract of the plant was
prepared according to (Science and Technology Program
for Development) CYTED protocol for vegetal species from
countries that are included in this Program [36]. Seeds were
powdered and then extracted in a soxhlet apparatus with
hexane. Seeds were then extracted with methanol and kept
for further studies. Methanol was completely evaporated in
a rotatory evaporator under vacuum. A blackish-brown dry
extract was obtained. It was kept at 4◦C until use.
4.4. Neuronal Primary Culture. Brain neurons were obtained
from foetal rat brains of 19 days of gestation as previously
described [37] with minor modiﬁcations. Isolated neurons
were suspended in Eagle’s Minimum Essential Medium
(EMEM) containing 0.3g/L glutamine, 0.6% glucose, 5%
Phosphate Buﬀered Saline (PBS), 5% Horse Serum (HS),
100U/mL penicillin and 100μg/mL streptomycin. Cells,
at a density of 1 × 106 cells/well, were placed on plastic
Petri dishes of 24 wells, treated with 10μg/mL poly-L-
lysine to aid attachment. The plates were incubated in a
humidiﬁed incubator in an atmosphere of 5% CO2/95% air
at 37
◦C. After 72hours, nonneuronal cells (contaminating
glial cells) were mitotically inhibited by exposure to cytosine
arabinoside. The incubation medium was replaced by fresh
medium to which cytosine arabinoside was added to a ﬁnal
concentration of 10μM.
After 3 days, this medium was replaced by fresh medium
and experiments were carried out using cultures ranging
from 10–15 days. Cell viability was checked by the dye
exclusion method. Viability was routinely >95%. Cell purity
was checked by both cells staining with cresyl violet to
identify neurons and with the speciﬁc antiglial ﬁbrillary
acidic protein (GFAP) antibody to identify glial cells.
4.5. Measurement of Glial Contamination. Cortical neurons,
after 7 days in culture, were detached from the culture plates
with trypsin solution (0.25% trypsin and 0.02% EDTA in
Dulbecco’s buﬀered saline without calcium and magnesium)
and then the cells were ﬁxed (during 30min) with 2% p-
formaldehyde. After two washes with 1mL of PBS, the cells
were treated (during 1h) with anti-GFAP antirabbit (at
dilution of 1/500). Subsequently, the cells were washed with
PBS and treated with antirabbit conjugated IgG FITC, at
1/100, for 30min. Cells were identiﬁed by ﬂow cytometry
analysis. Under these conditions, the glial cells in the cultures
were 8.3 ± 3.6% of the total (neural + glial cells).
4.6. Assessment of Cell Viability. Assessment of neuronal
injury was performed with the 3-(4,5-dimethylthiazol-2-yl)-
2,5diphenyltetrazolium bromide (MTT) assay. This assay
is used as an index of cell survival or cellular respiratory
capacity-based on method of Mossmann [38] and improved
by Weislow et al. [39] and Roehm et al. [40]. MTT assay
is an indicator of the mitochondrial activity of living
cells. The tetrazolium assay is based on the mitochondrial
dehydrogenases (MD) activity and their inactivation after
cell death. In live cells, MTT is reduced to a highly water-
soluble orange colored product, formazan dye. Neuronal
cellswereseededin96-multiwellplatesatadensityof36×103
cells/well(in200μLmedium)andkeptintheincubatoruntil
80–90%conﬂuence.Afterthis,themediumwasremovedand
the cells were washed twice with PBS and the NS extract
previously dissolved in PBS was added to the wells and
incubated for 15minutes or 1hour. After each one of the
treatment periods (15 or 60min), the medium was removed
and incubated with MTT solution (ﬁnal concentration
0.3mg/mL), according to the kit speciﬁcations. After 2h
incubation at 37
◦C in a humidiﬁed atmosphere, orange
dye solution was spectrophotometrically quantiﬁed using
an ELISA plate reader at 492nm. The amount of orange
formazan formed, as monitored by the absorbance, directly
correlates to the number of living cells. Results are expressed
as a percentage with respect to control (untreated cells). All
experiments were performed in triplicate.
4.7.MeasurementoftheAminoAcidSecretion. HPLCanalysis
of amino acids was performed by a previously described
method [41] with minor modiﬁcations and with the equip-
ment and conditions that were previously developed for
the amino acids determination [42]. Prior to HPLC amino
acid secretion analysis cells were washed twice, at 10min
intervals, with 1mL of Locke medium. After removing the
medium, cells were stimulated for 15min or 1hour at 37
◦C
with 250μL fresh Locke medium (control cells) or with
250μL of Locke medium containing the dry methanolic
extract of NS seeds at diﬀerent concentrations (2.5, 25 and
250μg/mL).
After stimulation, the wells medium (supernatant S1)
was taken for amino acid valuation and cells were then
stimulated with 250μL of 60mM KCl for 15min. After this,
the cells secretion (supernatant S2) was removed for their
valuation and cells were lysated with 250μL of distilled water
for total intracellular amino acids content determination.
The diﬀerent supernatants obtained, S1 and S2, as well as the
cell lysated, were lyophilized for their dansylation.
The content of the four amino acids present in the
methanolic extract was also determined by HPLC analysis
under the same conditions and these results were subtracted
from the total amino acids content in cellular medium
in presence of NS extract (S1) in order to obtain cellular
secretion value itself.
The results were calculated as the amino acid release
into the incubation medium with respect to the total amino
acid content. These results were expressed as a percentage
of secretion with respect to control experiments that were
considered as 100%.
4.8. Data Presentation. Data are presented as means ± SEM
of four separated experiments from diﬀerent cell cultures,
each one performed in triplicate with diﬀerent batches of
neuronal cells. Statistical comparisons were made using the
Student’s t-test.Journal of Biomedicine and Biotechnology 7
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